10-Q

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

SEC Filing Details

Document Details

Form
Filing Date
Aug 12, 2022
Document Date
Jun 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
KemPharm
Issuer
KEMPHARM, INC